Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Frontiers in Pharmacology|April 18, 2022
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for DepressionRoberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology|November 20, 2018
Predicting Responses to Psychedelics: A Prospective StudyEline C H M Haijen, Mendel Kaelen, Leor Roseman, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 26, 2011
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trialGlyn Lewis, Jean Mulligan, Nicola Wiles, et al.
Journal of Psychopharmacology (Oxford, England)|January 7, 2021
Acute acetate administration increases endogenous opioid levels in the human brain: A [<sup>11</sup>C]carfentanil molecular imaging studyAbhishekh H Ashok, Jim Myers, Gary Frost, et al.
Network Neuroscience (Cambridge, Mass.)|May 27, 2024
Effects of classic psychedelic drugs on turbulent signatures in brain dynamicsJosephine Cruzat, Yonatan Sanz Perl, Anira Escrichs, et al.
The Journal of Clinical Psychiatry|December 3, 2025
MAOI Antidepressants: A History Being RewrittenVincent Van den Eynde, Chittaranjan Andrade, Michael Berk, et al.
Public Health Genomics|May 31, 2016
Gene-Tailored Treatments for Brain Disorders: Challenges and OpportunitiesGiovanni Esposito, Jean Marc Burgunder, John Dunlop, et al.
Neuroscience Applied|July 14, 2025
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspectsDrummond E-Wen McCulloch, Matthias E Liechti, Kim Pc Kuypers, et al.
Journal of Psychopharmacology (Oxford, England)|April 24, 2019
Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivityMatthew B Wall, Rebecca Pope, Tom P Freeman, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 13, 2016
Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and geneticsBorwin Bandelow, David Baldwin, Marianna Abelli, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Frontiers in Pharmacology|April 18, 2022
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for DepressionRoberta Murphy, Hannes Kettner, Rick Zeifman, et al.
Frontiers in Pharmacology|November 20, 2018
Predicting Responses to Psychedelics: A Prospective StudyEline C H M Haijen, Mendel Kaelen, Leor Roseman, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 26, 2011
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trialGlyn Lewis, Jean Mulligan, Nicola Wiles, et al.
Journal of Psychopharmacology (Oxford, England)|January 7, 2021
Acute acetate administration increases endogenous opioid levels in the human brain: A [<sup>11</sup>C]carfentanil molecular imaging studyAbhishekh H Ashok, Jim Myers, Gary Frost, et al.
Network Neuroscience (Cambridge, Mass.)|May 27, 2024
Effects of classic psychedelic drugs on turbulent signatures in brain dynamicsJosephine Cruzat, Yonatan Sanz Perl, Anira Escrichs, et al.
The Journal of Clinical Psychiatry|December 3, 2025
MAOI Antidepressants: A History Being RewrittenVincent Van den Eynde, Chittaranjan Andrade, Michael Berk, et al.
Public Health Genomics|May 31, 2016
Gene-Tailored Treatments for Brain Disorders: Challenges and OpportunitiesGiovanni Esposito, Jean Marc Burgunder, John Dunlop, et al.
Neuroscience Applied|July 14, 2025
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspectsDrummond E-Wen McCulloch, Matthias E Liechti, Kim Pc Kuypers, et al.
Journal of Psychopharmacology (Oxford, England)|April 24, 2019
Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivityMatthew B Wall, Rebecca Pope, Tom P Freeman, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 13, 2016
Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and geneticsBorwin Bandelow, David Baldwin, Marianna Abelli, et al.
Pageof 18